{"nctId":"NCT01499368","briefTitle":"A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients","startDateStruct":{"date":"2011-11"},"conditions":["Erosive Esophagitis"],"count":495,"armGroups":[{"label":"Lafutidine","type":"EXPERIMENTAL","interventionNames":["Drug: Lafutidine"]},{"label":"Famotidine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Famotidine"]},{"label":"Omeprazole","type":"OTHER","interventionNames":["Drug: Omeprazole"]}],"interventions":[{"name":"Lafutidine","otherNames":[]},{"name":"Famotidine","otherNames":[]},{"name":"Omeprazole","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients who had symptoms of heartburn with a diagnosis of grade A to D reflux esophagitis according to the Los Angeles classification\n\nExclusion Criteria:\n\n* Gastric or duodenal ulcers (excluding ulcer scars)\n* Concurrent presence of Barrett's esophagus\n* A history of a poor response to H2RA or PPI given in the recommended dose for 8 weeks\n* Other conditions considered by the attending physician to potentially affect the assessment of efficacy and safety","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Recovery Rates of Reflux Esophagitis","description":"Recovery rates of reflux esophagitis on the Esophago Gastro Duodenoscopy test after 8 week treatment-FAS","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"101","spread":null},{"groupId":"OG001","value":"92","spread":null},{"groupId":"OG002","value":"126","spread":null}]},{"measurements":[{"groupId":"OG000","value":"43","spread":null},{"groupId":"OG001","value":"53","spread":null},{"groupId":"OG002","value":"21","spread":null}]}]}]},{"type":"SECONDARY","title":"The Proportion of Days Without 'Cardinal Symptom'","description":"The proportion of days without 'Cardinal symptom' after 4 or 8 week treatment-FAS 'Cardinal symptom': Burning sesation in the chest, Acid reflux, Heartburn including chest pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.64","spread":"0.31"},{"groupId":"OG001","value":"0.56","spread":"0.32"},{"groupId":"OG002","value":"0.69","spread":"0.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.77","spread":"0.27"},{"groupId":"OG001","value":"0.67","spread":"0.32"},{"groupId":"OG002","value":"0.82","spread":"0.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.77","spread":"0.27"},{"groupId":"OG001","value":"0.67","spread":"0.32"},{"groupId":"OG002","value":"0.82","spread":"0.24"}]}]}]},{"type":"SECONDARY","title":"The Proportion of Daytimes Without 'Cardinal Symptom'","description":"The proportion of daytimes without 'Cardinal symptom' after 4 or 8 week treatment-FAS 'Cardinal symptom': Burning sensation in the chest, Acid reflux, Heartburn including chest pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.74","spread":"0.27"},{"groupId":"OG001","value":"0.68","spread":"0.29"},{"groupId":"OG002","value":"0.77","spread":"0.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.83","spread":"0.23"},{"groupId":"OG001","value":"0.76","spread":"0.28"},{"groupId":"OG002","value":"0.87","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.83","spread":"0.23"},{"groupId":"OG001","value":"0.76","spread":"0.28"},{"groupId":"OG002","value":"0.87","spread":"0.20"}]}]}]},{"type":"SECONDARY","title":"The Proportion of Nighttimes Without 'Cardinal Symptom'","description":"The proportion of Nighttimes without 'Cardinal symptom' after 4 or 8 treatment-FAS 'Cardinal symptom': Burning sensation in the chest, Acid reflux, Heartburn including chest pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.75","spread":"0.27"},{"groupId":"OG001","value":"0.72","spread":"0.30"},{"groupId":"OG002","value":"0.82","spread":"0.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.87","spread":"0.19"},{"groupId":"OG001","value":"0.78","spread":"0.29"},{"groupId":"OG002","value":"0.89","spread":"0.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.87","spread":"0.19"},{"groupId":"OG001","value":"0.78","spread":"0.29"},{"groupId":"OG002","value":"0.89","spread":"0.18"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":165},"commonTop":["Nasopharyngitis","Abdominal pain","Dyspepsia","Headache","Alanine aminotransferase increased"]}}}